233 related articles for article (PubMed ID: 11340542)
1. Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteremia.
Krcmery V; Trupl J; Svetlansky I
Clin Infect Dis; 2001 Jun; 32(11):1656. PubMed ID: 11340542
[No Abstract] [Full Text] [Related]
2. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
[No Abstract] [Full Text] [Related]
3. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
4. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward.
Park YS; Kim SY; Park SY; Kang JH; Lee HS; Seo YH; Cho YK
Am J Infect Control; 2008 Feb; 36(1):29-32. PubMed ID: 18241733
[TBL] [Abstract][Full Text] [Related]
5. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
Safdar A; Rolston KV
Clin Infect Dis; 2007 Dec; 45(12):1602-9. PubMed ID: 18190323
[TBL] [Abstract][Full Text] [Related]
6. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
Gülmez D; Hasçelik G
Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
[TBL] [Abstract][Full Text] [Related]
8. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
9. Changing susceptibility patterns of nonfermenting Gram-negative bacilli.
Arora S; Gautam V; Ray P
Indian J Med Microbiol; 2012; 30(4):485-6. PubMed ID: 23183482
[No Abstract] [Full Text] [Related]
10. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
Nazik H; Ongen B; Erturan Z; Salcioğlu M
Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
[TBL] [Abstract][Full Text] [Related]
11. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and antimicrobial susceptibility of Stenotrophomonas maltophilia in a Bulgarian university hospital over a 5-year period (2007-2012).
Bojkova M; Markovska R; Stoeva T; Strateva T; Ivanova D; Popova V; Mitov I
Infect Dis (Lond); 2015; 47(12):932-4. PubMed ID: 26198085
[No Abstract] [Full Text] [Related]
13. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
Qamruddin AO; Alkawash MA; Soothill JS
Antimicrob Agents Chemother; 2005 Oct; 49(10):4425-6. PubMed ID: 16189141
[No Abstract] [Full Text] [Related]
16. Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia.
Korakianitis I; Mirtsou V; Gougoudi E; Raftogiannis M; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2010 Oct; 36(4):387-9. PubMed ID: 20674284
[No Abstract] [Full Text] [Related]
17. [An update on the susceptibility of Stenotrophomonas maltophilia].
Sevillano D; Valdezate S; Gómez-Lus ML
Rev Esp Quimioter; 2001 Jun; 14(2):138-54. PubMed ID: 11704768
[No Abstract] [Full Text] [Related]
18. Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Aug; 36(2):129-31. PubMed ID: 20472404
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea.
Apisarnthanarak A; Fraser VJ; Dunne WM; Little JR; Hoppe-Bauer J; Mayfield JL; Polish LB
Clin Infect Dis; 2003 Oct; 37(8):1131-5. PubMed ID: 14523780
[TBL] [Abstract][Full Text] [Related]
20. Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics.
Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Chung DR; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):210-2. PubMed ID: 27117514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
